No Result
View All Result
  • Login
Wednesday, June 24, 2026
theadvisertimes.com
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
No Result
View All Result
theadvisertimes.com
No Result
View All Result
Home Markets

The $4,200 Ozempic Ransom You Have to Pay Every Year to Keep the Weight Off

by theadvisertimes.com
5 months ago
in Markets
Reading Time: 3 mins read
A A
0
The ,200 Ozempic Ransom You Have to Pay Every Year to Keep the Weight Off
Share on FacebookShare on TwitterShare on LInkedIn


It feels like the weight-loss miracle so many have been waiting for. You watch the transformation videos on TikTok, see the celebrities shrinking before your eyes and hear the stories of friends who have effortlessly dropped 30 pounds.

Ozempic (semaglutide) has become the “Kleenex” of diet culture — a catch-all name for a weekly injection that melts fat without the misery of starvation.

But there’s a major catch. These drugs are not a cure. They are a treatment. Like blood pressure medication, they only work as long as you take them.

And there’s one crucial question every potential user should ask before their first dose: What happens when I stop?

The science of the rebound

Clinical trials paint a sobering picture for both major drug types.

For Ozempic and Wegovy (semaglutide) users, research found that one year after stopping the drug, participants regained two-thirds of their lost weight.

For Zepbound (tirzepatide) users, the news is similar. In a study of the drug, all participants took tirzepatide for 36 weeks and lost significant weight. Researchers then switched a randomized portion of the group to a placebo, at which point they regained 14% of their body weight in the following year, effectively erasing the majority of their progress.

It’s a matter of biology. When you lose weight rapidly, your body fights to get it back. It lowers your metabolism and ramps up your hunger hormones.

These drugs work by suppressing those signals. When you remove the drug, the dam breaks. Your body doesn’t just go back to normal. It often swings hard in the other direction to recover lost fat storage.

The return of ‘food noise’

One of the most praised effects of these drugs is the silencing of “food noise” — that constant mental chatter about what to eat next. For many users, this is the first time in their lives they haven’t felt obsessed with food.

When they stop the medication, that noise comes back, often louder than before.

Obesity specialists have noted that patients don’t just feel hungry; they feel an intense, biological drive to eat that can be overwhelming.

Because they haven’t necessarily built the psychological habits or muscle mass to maintain the weight naturally (since the drug did the heavy lifting), they’re left defenseless against these cravings.

The financial reality of a forever prescription

If you’re taking these drugs for weight loss, you need to budget for them like you would a utility bill.

As of early 2026, the pricing has shifted. While retail prices without insurance still hover near $1,000 per month, manufacturers have introduced new cash-pay options (like Zepbound vials or Wegovy intro offers) that can drop the price to the $199 to $399 range for eligible patients.

However, even at $350 a month, you’re looking at roughly $4,200 a year — indefinitely.

If you rely on insurance, remember that coverage is fickle. Medicare is starting to shift its rules regarding weight loss drugs, but there’s no guarantee of coverage. Other insurance coverage varies.

If you change jobs, lose coverage or your insurer changes their formulary, you could be forced to stop cold turkey and face the risk of regaining weight.

The health whiplash

Beyond the number on the scale, stopping these medications can shock your system.

Blood sugar spikes: If you were using these drugs for Type 2 diabetes or even pre-diabetes, stopping can cause your blood glucose levels to surge. This is dangerous and requires immediate management by a doctor.
Cardiometabolic regression: The clinical trials also found that improvements in cardiometabolic risk factors (like blood pressure and inflammation markers) reverted to baseline once the weight came back. You lose the heart health protection along with the weight.

Is it worth it?

This doesn’t mean you shouldn’t take them. For people with severe obesity or diabetes, these drugs are lifesavers. But you need to shift your mindset.

Don’t view Zepbound or Ozempic as a jumpstart to get skinny for a wedding or a reunion. Think of it instead as a lifetime management tool for a chronic condition.

If you aren’t willing — or financially able — to take it for the long haul, you might be setting yourself up for an expensive, heartbreaking cycle of yo-yo dieting that leaves you heavier than when you started.



Source link

Tags: OzempicPayransomweightyear
ShareTweetShare
Previous Post

ZOOZ provides Israelis with exposure to Bitcoin

Next Post

Where Prediction Markets Fit in Portfolios

Related Posts

Germany’s Political Class Wants Your Children for War

Germany’s Political Class Wants Your Children for War

by theadvisertimes.com
June 23, 2026
0

by Martin Armstrong German Defence Minister Boris Pistorius declared that “not all deployed soldiers will be volunteers” as Germany continues expanding its...

CFTC sues Kentucky over actions against prediction markets

CFTC sues Kentucky over actions against prediction markets

by theadvisertimes.com
June 23, 2026
0

Signage is seen outside of the Commodity Futures Trading Commission headquarters in Washington, Aug. 30, 2020.Andrew Kelly | ReutersThe Commodity...

Prediction market traders’ expectations for the NY primaries

Prediction market traders’ expectations for the NY primaries

by theadvisertimes.com
June 23, 2026
0

From left, Assemblymember Claire Valdez, a Democrat from New York and U.S. House candidate; Brad Lander, former New York City...

The Best Gas Price Savings and Rewards Apps to Battle High Fuel Costs

The Best Gas Price Savings and Rewards Apps to Battle High Fuel Costs

by theadvisertimes.com
June 23, 2026
0

Gas prices may be high across the country, but not every gas station chain’s prices and reward programs are equal....

Jack Henry (JKHY) Has a Core-Banking and Payments Workflow Engine Bigger Than a Regional-Bank Proxy Narrative

Jack Henry (JKHY) Has a Core-Banking and Payments Workflow Engine Bigger Than a Regional-Bank Proxy Narrative

by theadvisertimes.com
June 23, 2026
0

Jack Henry (JKHY) is often discussed as if it were just a cleaner way to express a view on community...

Meta is building a prediction markets app. These stocks are falling

Meta is building a prediction markets app. These stocks are falling

by theadvisertimes.com
June 23, 2026
0

Mark Zuckerberg, chief executive officer of Meta Platforms Inc., exits Los Angeles Superior Court in Los Angeles, California, US, on...

Next Post
Where Prediction Markets Fit in Portfolios

Where Prediction Markets Fit in Portfolios

Stephen Miller vs ICE Barbie & Corey Is a Distraction From Civil Conflict

Stephen Miller vs ICE Barbie & Corey Is a Distraction From Civil Conflict

  • Trending
  • Comments
  • Latest
Should You Offer a Concession to Get Your Apartment Leased Faster?

Should You Offer a Concession to Get Your Apartment Leased Faster?

June 15, 2026
Understanding risk remains a major investor blind spot: TIAA Institute

Understanding risk remains a major investor blind spot: TIAA Institute

June 5, 2026
6 Hotels Where Chase’s Points Boost Yields 2.5x

6 Hotels Where Chase’s Points Boost Yields 2.5x

May 22, 2026
Anthropic’s confidential S-1 signals summer AI IPO race could heat up fast

Anthropic’s confidential S-1 signals summer AI IPO race could heat up fast

June 2, 2026
Memorial Day 2026: Take Advantage of Food Freebies, Deals

Memorial Day 2026: Take Advantage of Food Freebies, Deals

May 23, 2026
9 Best Cheap Cell Phone Plans That Will Save You Money

9 Best Cheap Cell Phone Plans That Will Save You Money

June 3, 2026
Simad creditors extend loan to save company’s business

Simad creditors extend loan to save company’s business

0
CARCHEX 2026 Review: A Mid-Range Extended Car Warranty

CARCHEX 2026 Review: A Mid-Range Extended Car Warranty

0
Student loan FAQ: Everything borrowers are asking about the overhaul

Student loan FAQ: Everything borrowers are asking about the overhaul

0
Dollars And Sense At FinOps X 2026: Is AI Value Management Bigger Than FinOps?

Dollars And Sense At FinOps X 2026: Is AI Value Management Bigger Than FinOps?

0
Changes to BNY Pershing’s fees are a sign of the times

Changes to BNY Pershing’s fees are a sign of the times

0
Factory job cuts in June neared financial crisis and Covid levels, S&P says

Factory job cuts in June neared financial crisis and Covid levels, S&P says

0
Clay Craft India shares to list today. Check GMP ahead of debut

Clay Craft India shares to list today. Check GMP ahead of debut

June 23, 2026
Germany’s Political Class Wants Your Children for War

Germany’s Political Class Wants Your Children for War

June 23, 2026
US Senate Plans To Release Crypto Tax Bill By Fall 2026 Amid CLARITY Act Push

US Senate Plans To Release Crypto Tax Bill By Fall 2026 Amid CLARITY Act Push

June 23, 2026
CARCHEX 2026 Review: A Mid-Range Extended Car Warranty

CARCHEX 2026 Review: A Mid-Range Extended Car Warranty

June 23, 2026
SNAP Work Rules Now Apply to Adults 55-64—Why More Than 1 Million Older Americans Could Lose Food Assistance

SNAP Work Rules Now Apply to Adults 55-64—Why More Than 1 Million Older Americans Could Lose Food Assistance

June 23, 2026
South Korean digital bank with 15M users turns to Solana stablecoins for overseas transfers

South Korean digital bank with 15M users turns to Solana stablecoins for overseas transfers

June 23, 2026
theadvisertimes.com

Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.

CATEGORIES

  • Business
  • Cryptocurrency
  • Economy
  • Financial Planning
  • Investing
  • Market Analysis
  • Markets
  • Money
  • Personal Finance
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Clay Craft India shares to list today. Check GMP ahead of debut
  • Germany’s Political Class Wants Your Children for War
  • US Senate Plans To Release Crypto Tax Bill By Fall 2026 Amid CLARITY Act Push
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • About Us
  • Contact Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.